Perfil
Andy Rittenberg is currently Chief Legal Officer at Coherus Oncology, Inc. from 2024 to present.
Formerly, Mr. Rittenberg was Chief Compliance Officer & Senior VP-Legal at Gilead Sciences, Inc. from 2006 to 2023, and Attorney at Covington & Burling LLP from 1999 to 2006.
Education includes graduate studies at The University of Chicago and undergraduate studies at Yale University.
Cargos activos de Andy Rittenberg
| Empresas | Cargo | Inicio |
|---|---|---|
| COHERUS ONCOLOGY, INC. | Consejero General | 01/01/2024 |
Antiguos cargos conocidos de Andy Rittenberg.
| Empresas | Cargo | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Oficial de Cumplimiento | 01/08/2023 |
Covington & Burling LLP
Covington & Burling LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/04/2006 |
Formación de Andy Rittenberg.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Covington & Burling LLP
Covington & Burling LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
- Bolsa de valores
- Insiders
- Andy Rittenberg
















